Reports

- Global Locations -

Headquarters

Future Market Insights, Inc.

Christiana Corporate, 200
Continental Drive, Suite 401,
Newark, Delaware - 19713,
United States

T: +1-845-579-5705

Americas

Future Market Insights, Inc.

616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989, United States

T: +1-347-918-3531

MEA

Future Market Insights

1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates

Europe

Future Market Insights

3rd Floor, 207 Regent Street,
W1B 3HH London
United Kingdom

T: + 44 (0) 20 8123 9659
D: +44 (0) 20 3287 4268

Asia Pacific

Future Market Insights

IndiaLand Global Tech Park, Unit UG-1, Behind Grand HighStreet, Phase 1, Hinjawadi, MH, Pune – 411057, India

Female Pelvic Implants Market Snapshot (2023 to 2033)

The female pelvic implants market is projected to account for sales worth US$ 258.91 million by 2023. The market is projected to observe a CAGR of 2.8% in the forecast period, reaching US$ 341.26 million by 2033.

As per FMI, the top five players comprising Johnson & Johnson, Coloplast A/S, Becton, Dickinson and Company, Boston Scientific Corporation, and Cook Medical constitute around 75% of the overall market.

Market to Gain from Novel Tissue Engineering Launch for Female Pelvic Floor Reconstruction

Ongoing post-marketing surveillance of approved devices and the introduction of novel tissue engineering in female pelvic floor reconstruction creates huge opportunities in the female pelvic implants industry. The majority of manufacturers are selling their products in the global market despite strict regulations.

After the Food and Drug Administration’s (FDA) reclassification of vaginal mesh implants from Class II to Class III medical devices, the FDA has advised 33 manufacturers to conduct 3-year studies. It is to assess the impact of organ damage and other complications of mesh implants.

After assessing the risks, the manufacturers can reintroduce their devices and can get pre-market approval from the FDA. Further, this allows manufacturers to re-launch mesh implants, which are expected to enter the market. Similarly, the introduction of novel tissue engineering with growth factors, biomaterials, and drugs implanted into tissue damage or loss is set to boost repair time, stimulating the regeneration of damaged tissue.

Studies initiating tissue engineering for pelvic organ prolapse have reported the use of novel designed knit material fabricated from FDA-approved non-degradable polyamide dip-coated in gelatin for MSC seeding and delivery.

Polypropylene mesh commonly used in clinical practice has good mechanical properties, but there are long-term complications. This validates the need for tissue engineering technology in the treatment of pelvic organ prolapse and promotes an innovative approach to pelvic implantation.

What are the Factors Restraining Demand for Female Pelvic Implants?

As per the USFDA, the transvaginal placement of surgical mesh can be risky in women with POP mesh complications. Some of the common complications reported include mesh erosion, infections, vaginal scarring, discomfort and pain during sex, and even a resurgence of urinary incontinence.

Through January 31, 2019, over 139,000 adverse events have been reported for mesh products of which over 69,000 events were reported for POP mesh products, as per FDA, 2020. This restricts the patients from taking surgeries to implant vaginal mesh, thereby deterring market growth.

Growing awareness of surgical complications is curbing patients from opting for vaginal mesh implants in the high-growth markets of Europe and the United States.

Attributes Details
Female Pelvic Implants Market Size (2023) US$ 258.91 million
Female Pelvic Implants Market Size (2033) US$ 341.26 million
Female Pelvic Implants Market CAGR (2023 to 2033) 2.8%
Female Pelvic Implants Market Size (2022) US$ 251.86 million

Don't pay for what you don't need

Customize your report by selecting specific countries or regions and save 30%!

2018 to 2022 Female Pelvic Implants Market Outlook Compared to 2023 to 2033 Forecast

According to Future Market Insights (FMI), the demand for female pelvic implants has grown at a 2.5% CAGR between 2018 and 2022.

According to the Division of Female Pelvic Medicine and Reconstructive Surgery at Northwestern University Chicago, women with normal life expectancy have an average 30-50% chance of developing pelvic organ prolapse. Around 19% of these women need to undergo at least one surgical intervention for POP or SUI and 30% of them undergo reoperation for recurrence. Despite such high prevalence, there is no definite cure or restoration of anatomical defects for pelvic organ prolapse or stress urinary incontinence.

In the last two decades, many efforts have been made to improve the outcomes of surgery. However, the majority of such efforts have resulted in the use of vaginal mesh and grafts. So far, surgical options with mesh implants and slings are proving to be the best option for such disorders which imply a heavy social and economic burden.

Other surgical options such as allografts and xenografts are costly and carry the potential of transmission of infectious disease and synthetic meshes. Thus, the market for female pelvic implants is expected to see continuous growth in the use of mesh and sling implants until definite alternatives are available for these products.

Future Market Insights expects the global female pelvic implants industry to rise at 2.8% CAGR between 2023 and 2033.

Comparative View of the Female Pelvic Implants Market

Female Pelvic Implants Market:

Attributes Female Pelvic Implants Market
CAGR (2023 to 2033) 2.8%
Market Value (2033) US$ 341.26 million
Opportunity Vigorous attempts by healthcare professionals to actively promote awareness about urinary continence in the majority of care settings.
Key Trends Increasing cases of stress urinary incontinence (SUI) to govern market growth in the following years.

Female Stress Urinary Incontinence Treatment Devices Market:

Attributes Female Stress Urinary Incontinence Treatment Devices Market
CAGR (2023 to 2033) 6.2%
Market Value (2033) US$ 1.36 billion
Opportunity The rampant increase in gynecologic disorders and urinary incontinence is catalyzing the increase in demand.
Key Trends The debut of intravaginal devices and surge in the radiofrequency treatments to manage female SUI is expected to fuel market growth.

Infectious Disease Diagnostics Market:

Attributes Infectious Disease Diagnostics Market
CAGR (2023 to 2033) 7%
Market Value (2033) US$ 3.72 billion
Opportunity Increasing proclivity for point-of-care testing is propelling big companies to focus on development projects to deliver point-of-care diagnostic solutions in developing countries.
Key Trends Numerous government-funded programs are providing free screening and tests worldwide, thus enlarging the market.
Sabyasachi Ghosh
Sabyasachi Ghosh

Principal Consultant

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Country-wise Insights

How is the Female Pelvic Implants Market Faring in the United States?

The United States holds over 83% share of the female pelvic implants market in North America. As per the records of the Association for Pelvic Organ Prolapse Support, nearly 34 million women suffer from pelvic organ prolapse (POP) across the globe currently.

In the United States, the overall number of patients with POP is 3.3 million. According to the National Association for Incontinence, 25 million people in the United States suffer from some form of urinary incontinence, out of which 75% are women. Stress urinary incontinence (SUI) is the most prevalent form.

In the United States, about 15 million people are suffering from SUI. Thus, the rising prevalence of pelvic organ prolapse and stress urinary incontinence is driving the United States female pelvic implant market.

How is Support for Women Post-Operation Driving Demand for Female Pelvic Implants in the United Kingdom?

The United Kingdom market accounts for over 13% of Europe market through the assessment period ending in 2033. The governments of various countries in Europe like the United Kingdom are forming committees that can address the issues of women suffering from peri-operative complications of surgeries for pelvic implants. These programs are expected to raise awareness among patients, hospitals, and GPs and can increase the penetration of female pelvic implants over the forecast period. For instance,

  • Hospitals in the United Kingdom are forming a multidisciplinary team (MDT) consisting of specialists from urogynecology, urology, radiology, pain management, and more, to provide advice and treatment. This MDT assesses complications and advises the patient if surgery to treat mesh complications is needed.

What is the Scope of Growth of Female Pelvic Implants Sales in India Market?

India’s market accounts for more than 30% of the sales registered in South Asia in 2021. Most developing countries have patients that are not aware of conditions such as pelvic organ prolapse and stress urinary incontinence.

Perception of pain associated with surgery evokes considerable anxiety in patients resulting in a reluctance to consider surgical options to cure SUI or POP. Many women delay or do not seek treatment for these diseases in India due to a lack of awareness. It is forecasted to be the big challenge for the growth of female pelvic implants in India market.

What Factors are Driving Revenue Generation in the Australia market?

Country Australia
Forecast CAGR % (2023 to 2033) 2.8%

The market for female pelvic Implants in Australia is exhibiting a 2.8% CAGR and is projected to account for more than 86% of Oceania market throughout the projection period. Growing government initiatives to create awareness are anticipated to boost growth in the region. For instance,

  • The government of Australia has developed the Continence Aids Payment Scheme (CAPS) to support patients with severe incontinence problems. Furthermore, professionals, such as urologists, urogynecologists, gynecologists, nurses, and other skilled organizations have actively promoted awareness of urinary continence in all care settings.

Category-wise Insights

Why are Vaginal Sling/Tapes Key to Revenue Generation?

Segment Vaginal Sling/Tapes
Forecast CAGR (2023 to 2033) 2.5%

Vaginal sling/tapes have a high growth potential. The segment is likely to expand with a relatively high CAGR of 2.5% in the forthcoming years. Vaginal sling/tape implants are generally made from a narrow ‘tape’ of polypropylene mesh which is placed under the urethra like a sling or hammock to keep the urethra in the correct position.

Vaginal slings have been on the market for about 20 years and can be implanted in half-hour. The minimally invasive surgical procedure under local anesthesia is preferred for outpatient applications. Owing to these advantages, demand for vaginal sling/tapes is increasing during the forecast period.

Is the Stress Urinary Incontinence (SUI) Projected to Continue Fueling Female Pelvic Implants Demand?

The stress urinary incontinence (SUI) segment is expected to contribute maximum revenue share in the global female pelvic implants market. In terms of revenue, the stress urinary incontinence (SUI) segment accounted for over 58% share in 2022.

The demand for female pelvic implants is likely to witness solid growth on account of the prevalence of stress urinary incontinence and rising awareness among women regarding treatment options on a global scale.

What is the Scope of Sales across Hospitals?

Segment Hospitals
Forecast CAGR (2023 to 2033) 2.2%

Hospitals are currently the leading end users of female pelvic implants with a 2.2% CAGR through the forecast period. Similarly, hospitals can impact high investment abilities and capital, with the surge in the number of emergency admissions, which is projected to enhance growth prospects for the long term.

Get the data you need at a Fraction of the cost

Personalize your report by choosing insights you need
and save 40%!

What are the Winning Strategies Adopted by Key Players?

Manufacturers are primarily focusing on developing new products to bolster the acceptance of female pelvic implants, thus anticipating the surge in sales figures. Further, the companies are focusing on outsourcing the production of female pelvic implants to reduce manufacturing costs, thereby challenging the market with reduced costs.

Key players are entering into collaborations, partnerships, acquisitions, and mergers to strengthen their product lines and global market.

  • Betatech Medical participated in Expomed 2018 which was held in Istanbul on the 28th of February. Betatech developed uterine and pelvic surgical slings and mesh.
  • In August 2020, InterStim announced the receipt of FDA approval for its Micro neurostimulator and SureScan MRI for non-obstructive urinary retention, overactive bladder, and fecal incontinence.

Key Players Working in the Market:

  • Johnson & Johnson Services, Inc.
  • Coloplast A/S
  • Dipromed Srl
  • Boston Scientific Corporation
  • pfm medical ag
  • Betatech Medical
  • Promedon Group
  • Caldera Medical
  • Cook Medical

Scope of the Female Pelvic Implants Market Report

Attribute Details
Forecast Period 2023 to 2033
Historical Data Available for 2018 to 2022
Market Analysis US$ Million for Value in Million
Key Regions Covered North America, Latin America, Europe, East Asia, South Asia, Oceania Middle East & Africa
Key Countries Covered The United States, Canada, the United Kingdom, Germany, Italy, France, Spain, Benelux, Russia, India, Thailand, Malaysia, Indonesia, China, Japan, South Korea, Australia, New Zealand, GCC Countries, South Africa and North Africa
Key Segments Covered Product Type, Indication, End User, and Region
Key Companies Profiled
  • Johnson & Johnson Services, Inc.
  • Coloplast A/S
  • Dipromed Srl
  • Boston Scientific Corporation
  • pfm medical ag
  • Betatech Medical
  • Promedon Group
  • Caldera Medical
  • Cook Medical
Report Coverage Market Forecast, Competition Intelligence, DROT Analysis, Market Dynamics and Challenges, Strategic Growth Initiatives
Customization & Pricing Available upon Request

Market Taxonomy by Category

By Product Type:

  • Vaginal Mesh Implants
  • Vaginal Sling
  • Vaginal Graft Implants

By Indication:

  • Pelvic Organ Prolapse
  • Stress Urinary Incontinence

By End User:

  • Hospitals
  • Ambulatory Surgical Centers
  • Specialty Clinics

By Region:

  • North America
  • Latin America
  • China
  • Western Europe
  • Eastern Europe
  • Asia Pacific
  • The Middle East and Africa

Frequently Asked Questions

What is the Female Pelvic Implants Market CAGR from 2023 to 2033?

The CAGR for the market is 2.8% until 2033.

What is the market’s historical performance?

From 2018 to 2022, the market expanded at an 2.5% CAGR.

What is the 2023 market value?

The market in 2023 totals US$ 258.91 million.

Who are some key market players?

Promedon Group, Caldera Medical, Cook Medical are some key players.

What is the expected market value in 2033?

The market will reach US$ 341.26 million by 2033.

Table of Content

1. Executive Summary

    1.1. Global Market Outlook

    1.2. Demand-side Trends

    1.3. Supply-side Trends

    1.4. Technology Roadmap Analysis

    1.5. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

3. Market Background

    3.1. Market Dynamics

        3.1.1. Drivers

        3.1.2. Restraints

        3.1.3. Opportunity

        3.1.4. Trends

    3.2. Scenario Forecast

        3.2.1. Demand in Optimistic Scenario

        3.2.2. Demand in Likely Scenario

        3.2.3. Demand in Conservative Scenario

    3.3. Opportunity Map Analysis

    3.4. Investment Feasibility Matrix

    3.5. PESTLE and Porter’s Analysis

    3.6. Regulatory Landscape

        3.6.1. By Key Regions

        3.6.2. By Key Countries

    3.7. Regional Parent Market Outlook

4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033

    4.1. Historical Market Size Value (US$ Million) Analysis, 2018 to 2022

    4.2. Current and Future Market Size Value (US$ Million) Projections, 2023 to 2033

        4.2.1. Y-o-Y Growth Trend Analysis

        4.2.2. Absolute $ Opportunity Analysis

5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Product Type

    5.1. Introduction / Key Findings

    5.2. Historical Market Size Value (US$ Million) Analysis By Product Type, 2018 to 2022

    5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Product Type, 2023 to 2033

        5.3.1. Vaginal Mesh Implants

        5.3.2. Vaginal Sling

        5.3.3. Vaginal Graft Implants

    5.4. Y-o-Y Growth Trend Analysis By Product Type, 2018 to 2022

    5.5. Absolute $ Opportunity Analysis By Product Type, 2023 to 2033

6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Indication

    6.1. Introduction / Key Findings

    6.2. Historical Market Size Value (US$ Million) Analysis By Indication, 2018 to 2022

    6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Indication, 2023 to 2033

        6.3.1. Pelvic Organ Prolapse

        6.3.2. Stress Urinary Incontinence

    6.4. Y-o-Y Growth Trend Analysis By Indication, 2018 to 2022

    6.5. Absolute $ Opportunity Analysis By Indication, 2023 to 2033

7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By End User

    7.1. Introduction / Key Findings

    7.2. Historical Market Size Value (US$ Million) Analysis By End User, 2018 to 2022

    7.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By End User, 2023 to 2033

        7.3.1. Hospitals

        7.3.2. Ambulatory Surgical Centres

        7.3.3. Speciality Clinics

    7.4. Y-o-Y Growth Trend Analysis By End User, 2018 to 2022

    7.5. Absolute $ Opportunity Analysis By End User, 2023 to 2033

8. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region

    8.1. Introduction

    8.2. Historical Market Size Value (US$ Million) Analysis By Region, 2018 to 2022

    8.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2023 to 2033

        8.3.1. North America

        8.3.2. Latin America

        8.3.3. Western Europe

        8.3.4. Eastern Europe

        8.3.5. South Asia and Pacific

        8.3.6. East Asia

        8.3.7. Middle East & Africa

    8.4. Market Attractiveness Analysis By Region

9. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    9.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

    9.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        9.2.1. By Country

            9.2.1.1. USA

            9.2.1.2. Canada

        9.2.2. By Product Type

        9.2.3. By Indication

        9.2.4. By End User

    9.3. Market Attractiveness Analysis

        9.3.1. By Country

        9.3.2. By Product Type

        9.3.3. By Indication

        9.3.4. By End User

    9.4. Key Takeaways

10. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    10.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

    10.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        10.2.1. By Country

            10.2.1.1. Brazil

            10.2.1.2. Mexico

            10.2.1.3. Argentina

            10.2.1.4. Rest of Latin America

        10.2.2. By Product Type

        10.2.3. By Indication

        10.2.4. By End User

    10.3. Market Attractiveness Analysis

        10.3.1. By Country

        10.3.2. By Product Type

        10.3.3. By Indication

        10.3.4. By End User

    10.4. Key Takeaways

11. Western Europe  Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

    11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        11.2.1. By Country

            11.2.1.1. UK

            11.2.1.2. Germany

            11.2.1.3. France

            11.2.1.4. Italy

            11.2.1.5. Spain

            11.2.1.6. Rest of Western Europe

        11.2.2. By Product Type

        11.2.3. By Indication

        11.2.4. By End User

    11.3. Market Attractiveness Analysis

        11.3.1. By Country

        11.3.2. By Product Type

        11.3.3. By Indication

        11.3.4. By End User

    11.4. Key Takeaways

12. Eastern Europe  Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

    12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        12.2.1. By Country

            12.2.1.1. Russia

            12.2.1.2. Poland

            12.2.1.3. Czech Republic

            12.2.1.4. Romania

            12.2.1.5. Rest of Eastern Europe

        12.2.2. By Product Type

        12.2.3. By Indication

        12.2.4. By End User

    12.3. Market Attractiveness Analysis

        12.3.1. By Country

        12.3.2. By Product Type

        12.3.3. By Indication

        12.3.4. By End User

    12.4. Key Takeaways

13. South Asia and Pacific  Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    13.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

    13.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        13.2.1. By Country

            13.2.1.1. India

            13.2.1.2. Bangladesh

            13.2.1.3. Australia

            13.2.1.4. New Zealand

            13.2.1.5. Rest of South Asia and Pacific

        13.2.2. By Product Type

        13.2.3. By Indication

        13.2.4. By End User

    13.3. Market Attractiveness Analysis

        13.3.1. By Country

        13.3.2. By Product Type

        13.3.3. By Indication

        13.3.4. By End User

    13.4. Key Takeaways

14. East Asia  Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    14.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

    14.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        14.2.1. By Country

            14.2.1.1. China

            14.2.1.2. Japan

            14.2.1.3. South Korea

        14.2.2. By Product Type

        14.2.3. By Indication

        14.2.4. By End User

    14.3. Market Attractiveness Analysis

        14.3.1. By Country

        14.3.2. By Product Type

        14.3.3. By Indication

        14.3.4. By End User

    14.4. Key Takeaways

15. Middle East & Africa Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    15.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

    15.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        15.2.1. By Country

            15.2.1.1. Iran

            15.2.1.2. Turkey

            15.2.1.3. Rest of MEA

        15.2.2. By Product Type

        15.2.3. By Indication

        15.2.4. By End User

    15.3. Market Attractiveness Analysis

        15.3.1. By Country

        15.3.2. By Product Type

        15.3.3. By Indication

        15.3.4. By End User

    15.4. Key Takeaways

16. Key Countries Market Analysis

    16.1. USA

        16.1.1. Pricing Analysis

        16.1.2. Market Share Analysis, 2022

            16.1.2.1. By Product Type

            16.1.2.2. By Indication

            16.1.2.3. By End User

    16.2. Canada

        16.2.1. Pricing Analysis

        16.2.2. Market Share Analysis, 2022

            16.2.2.1. By Product Type

            16.2.2.2. By Indication

            16.2.2.3. By End User

    16.3. Brazil

        16.3.1. Pricing Analysis

        16.3.2. Market Share Analysis, 2022

            16.3.2.1. By Product Type

            16.3.2.2. By Indication

            16.3.2.3. By End User

    16.4. Mexico

        16.4.1. Pricing Analysis

        16.4.2. Market Share Analysis, 2022

            16.4.2.1. By Product Type

            16.4.2.2. By Indication

            16.4.2.3. By End User

    16.5. Argentina

        16.5.1. Pricing Analysis

        16.5.2. Market Share Analysis, 2022

            16.5.2.1. By Product Type

            16.5.2.2. By Indication

            16.5.2.3. By End User

    16.6. UK

        16.6.1. Pricing Analysis

        16.6.2. Market Share Analysis, 2022

            16.6.2.1. By Product Type

            16.6.2.2. By Indication

            16.6.2.3. By End User

    16.7. Germany

        16.7.1. Pricing Analysis

        16.7.2. Market Share Analysis, 2022

            16.7.2.1. By Product Type

            16.7.2.2. By Indication

            16.7.2.3. By End User

    16.8. France

        16.8.1. Pricing Analysis

        16.8.2. Market Share Analysis, 2022

            16.8.2.1. By Product Type

            16.8.2.2. By Indication

            16.8.2.3. By End User

    16.9. Italy

        16.9.1. Pricing Analysis

        16.9.2. Market Share Analysis, 2022

            16.9.2.1. By Product Type

            16.9.2.2. By Indication

            16.9.2.3. By End User

    16.10. Spain

        16.10.1. Pricing Analysis

        16.10.2. Market Share Analysis, 2022

            16.10.2.1. By Product Type

            16.10.2.2. By Indication

            16.10.2.3. By End User

    16.11. Russia

        16.11.1. Pricing Analysis

        16.11.2. Market Share Analysis, 2022

            16.11.2.1. By Product Type

            16.11.2.2. By Indication

            16.11.2.3. By End User

    16.12. Poland

        16.12.1. Pricing Analysis

        16.12.2. Market Share Analysis, 2022

            16.12.2.1. By Product Type

            16.12.2.2. By Indication

            16.12.2.3. By End User

    16.13. Czech Republic

        16.13.1. Pricing Analysis

        16.13.2. Market Share Analysis, 2022

            16.13.2.1. By Product Type

            16.13.2.2. By Indication

            16.13.2.3. By End User

    16.14. Romania

        16.14.1. Pricing Analysis

        16.14.2. Market Share Analysis, 2022

            16.14.2.1. By Product Type

            16.14.2.2. By Indication

            16.14.2.3. By End User

    16.15. India

        16.15.1. Pricing Analysis

        16.15.2. Market Share Analysis, 2022

            16.15.2.1. By Product Type

            16.15.2.2. By Indication

            16.15.2.3. By End User

    16.16. Bangladesh

        16.16.1. Pricing Analysis

        16.16.2. Market Share Analysis, 2022

            16.16.2.1. By Product Type

            16.16.2.2. By Indication

            16.16.2.3. By End User

    16.17. Australia

        16.17.1. Pricing Analysis

        16.17.2. Market Share Analysis, 2022

            16.17.2.1. By Product Type

            16.17.2.2. By Indication

            16.17.2.3. By End User

    16.18. New Zealand

        16.18.1. Pricing Analysis

        16.18.2. Market Share Analysis, 2022

            16.18.2.1. By Product Type

            16.18.2.2. By Indication

            16.18.2.3. By End User

    16.19. China

        16.19.1. Pricing Analysis

        16.19.2. Market Share Analysis, 2022

            16.19.2.1. By Product Type

            16.19.2.2. By Indication

            16.19.2.3. By End User

    16.20. Japan

        16.20.1. Pricing Analysis

        16.20.2. Market Share Analysis, 2022

            16.20.2.1. By Product Type

            16.20.2.2. By Indication

            16.20.2.3. By End User

    16.21. South Korea

        16.21.1. Pricing Analysis

        16.21.2. Market Share Analysis, 2022

            16.21.2.1. By Product Type

            16.21.2.2. By Indication

            16.21.2.3. By End User

    16.22. Iran

        16.22.1. Pricing Analysis

        16.22.2. Market Share Analysis, 2022

            16.22.2.1. By Product Type

            16.22.2.2. By Indication

            16.22.2.3. By End User

    16.23. Turkey

        16.23.1. Pricing Analysis

        16.23.2. Market Share Analysis, 2022

            16.23.2.1. By Product Type

            16.23.2.2. By Indication

            16.23.2.3. By End User

17. Market Structure Analysis

    17.1. Competition Dashboard

    17.2. Competition Benchmarking

    17.3. Market Share Analysis of Top Players

        17.3.1. By Regional

        17.3.2. By Product Type

        17.3.3. By Indication

        17.3.4. By End User

18. Competition Analysis

    18.1. Competition Deep Dive

        18.1.1. Johnson & Johnson Services, Inc.

            18.1.1.1. Overview

            18.1.1.2. Product Portfolio

            18.1.1.3. Profitability by Market Segments

            18.1.1.4. Sales Footprint

            18.1.1.5. Strategy Overview

                18.1.1.5.1. Marketing Strategy

        18.1.2. Coloplast A/S

            18.1.2.1. Overview

            18.1.2.2. Product Portfolio

            18.1.2.3. Profitability by Market Segments

            18.1.2.4. Sales Footprint

            18.1.2.5. Strategy Overview

                18.1.2.5.1. Marketing Strategy

        18.1.3. Dipromed Srl

            18.1.3.1. Overview

            18.1.3.2. Product Portfolio

            18.1.3.3. Profitability by Market Segments

            18.1.3.4. Sales Footprint

            18.1.3.5. Strategy Overview

                18.1.3.5.1. Marketing Strategy

        18.1.4. Boston Scientific Corporation

            18.1.4.1. Overview

            18.1.4.2. Product Portfolio

            18.1.4.3. Profitability by Market Segments

            18.1.4.4. Sales Footprint

            18.1.4.5. Strategy Overview

                18.1.4.5.1. Marketing Strategy

        18.1.5. pfm medical ag

            18.1.5.1. Overview

            18.1.5.2. Product Portfolio

            18.1.5.3. Profitability by Market Segments

            18.1.5.4. Sales Footprint

            18.1.5.5. Strategy Overview

                18.1.5.5.1. Marketing Strategy

        18.1.6. Betatech Medical

            18.1.6.1. Overview

            18.1.6.2. Product Portfolio

            18.1.6.3. Profitability by Market Segments

            18.1.6.4. Sales Footprint

            18.1.6.5. Strategy Overview

                18.1.6.5.1. Marketing Strategy

        18.1.7. Promedon Group

            18.1.7.1. Overview

            18.1.7.2. Product Portfolio

            18.1.7.3. Profitability by Market Segments

            18.1.7.4. Sales Footprint

            18.1.7.5. Strategy Overview

                18.1.7.5.1. Marketing Strategy

        18.1.8. Caldera Medical

            18.1.8.1. Overview

            18.1.8.2. Product Portfolio

            18.1.8.3. Profitability by Market Segments

            18.1.8.4. Sales Footprint

            18.1.8.5. Strategy Overview

                18.1.8.5.1. Marketing Strategy

        18.1.9. Cook Medical

            18.1.9.1. Overview

            18.1.9.2. Product Portfolio

            18.1.9.3. Profitability by Market Segments

            18.1.9.4. Sales Footprint

            18.1.9.5. Strategy Overview

                18.1.9.5.1. Marketing Strategy

19. Assumptions & Acronyms Used

20. Research Methodology

Don't pay for what you don't need

Customize your report by selecting specific countries or regions and save 30%!

List of Tables

Table 1: Global Market Value (US$ Million) Forecast by Region, 2018 to 2033

Table 2: Global Market Value (US$ Million) Forecast by Product Type, 2018 to 2033

Table 3: Global Market Value (US$ Million) Forecast by Indication, 2018 to 2033

Table 4: Global Market Value (US$ Million) Forecast by End User, 2018 to 2033

Table 5: North America Market Value (US$ Million) Forecast by Country, 2018 to 2033

Table 6: North America Market Value (US$ Million) Forecast by Product Type, 2018 to 2033

Table 7: North America Market Value (US$ Million) Forecast by Indication, 2018 to 2033

Table 8: North America Market Value (US$ Million) Forecast by End User, 2018 to 2033

Table 9: Latin America Market Value (US$ Million) Forecast by Country, 2018 to 2033

Table 10: Latin America Market Value (US$ Million) Forecast by Product Type, 2018 to 2033

Table 11: Latin America Market Value (US$ Million) Forecast by Indication, 2018 to 2033

Table 12: Latin America Market Value (US$ Million) Forecast by End User, 2018 to 2033

Table 13: Western Europe  Market Value (US$ Million) Forecast by Country, 2018 to 2033

Table 14: Western Europe  Market Value (US$ Million) Forecast by Product Type, 2018 to 2033

Table 15: Western Europe  Market Value (US$ Million) Forecast by Indication, 2018 to 2033

Table 16: Western Europe  Market Value (US$ Million) Forecast by End User, 2018 to 2033

Table 17: Eastern Europe  Market Value (US$ Million) Forecast by Country, 2018 to 2033

Table 18: Eastern Europe  Market Value (US$ Million) Forecast by Product Type, 2018 to 2033

Table 19: Eastern Europe  Market Value (US$ Million) Forecast by Indication, 2018 to 2033

Table 20: Eastern Europe  Market Value (US$ Million) Forecast by End User, 2018 to 2033

Table 21: South Asia and Pacific  Market Value (US$ Million) Forecast by Country, 2018 to 2033

Table 22: South Asia and Pacific  Market Value (US$ Million) Forecast by Product Type, 2018 to 2033

Table 23: South Asia and Pacific  Market Value (US$ Million) Forecast by Indication, 2018 to 2033

Table 24: South Asia and Pacific  Market Value (US$ Million) Forecast by End User, 2018 to 2033

Table 25: East Asia  Market Value (US$ Million) Forecast by Country, 2018 to 2033

Table 26: East Asia  Market Value (US$ Million) Forecast by Product Type, 2018 to 2033

Table 27: East Asia  Market Value (US$ Million) Forecast by Indication, 2018 to 2033

Table 28: East Asia  Market Value (US$ Million) Forecast by End User, 2018 to 2033

Table 29: Middle East & Africa Market Value (US$ Million) Forecast by Country, 2018 to 2033

Table 30: Middle East & Africa Market Value (US$ Million) Forecast by Product Type, 2018 to 2033

Table 31: Middle East & Africa Market Value (US$ Million) Forecast by Indication, 2018 to 2033

Table 32: Middle East & Africa Market Value (US$ Million) Forecast by End User, 2018 to 2033
Sabyasachi Ghosh
Sabyasachi Ghosh

Principal Consultant

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

List of Charts

Figure 1: Global Market Value (US$ Million) by Product Type, 2023 to 2033

Figure 2: Global Market Value (US$ Million) by Indication, 2023 to 2033

Figure 3: Global Market Value (US$ Million) by End User, 2023 to 2033

Figure 4: Global Market Value (US$ Million) by Region, 2023 to 2033

Figure 5: Global Market Value (US$ Million) Analysis by Region, 2018 to 2033

Figure 6: Global Market Value Share (%) and BPS Analysis by Region, 2023 to 2033

Figure 7: Global Market Y-o-Y Growth (%) Projections by Region, 2023 to 2033

Figure 8: Global Market Value (US$ Million) Analysis by Product Type, 2018 to 2033

Figure 9: Global Market Value Share (%) and BPS Analysis by Product Type, 2023 to 2033

Figure 10: Global Market Y-o-Y Growth (%) Projections by Product Type, 2023 to 2033

Figure 11: Global Market Value (US$ Million) Analysis by Indication, 2018 to 2033

Figure 12: Global Market Value Share (%) and BPS Analysis by Indication, 2023 to 2033

Figure 13: Global Market Y-o-Y Growth (%) Projections by Indication, 2023 to 2033

Figure 14: Global Market Value (US$ Million) Analysis by End User, 2018 to 2033

Figure 15: Global Market Value Share (%) and BPS Analysis by End User, 2023 to 2033

Figure 16: Global Market Y-o-Y Growth (%) Projections by End User, 2023 to 2033

Figure 17: Global Market Attractiveness by Product Type, 2023 to 2033

Figure 18: Global Market Attractiveness by Indication, 2023 to 2033

Figure 19: Global Market Attractiveness by End User, 2023 to 2033

Figure 20: Global Market Attractiveness by Region, 2023 to 2033

Figure 21: North America Market Value (US$ Million) by Product Type, 2023 to 2033

Figure 22: North America Market Value (US$ Million) by Indication, 2023 to 2033

Figure 23: North America Market Value (US$ Million) by End User, 2023 to 2033

Figure 24: North America Market Value (US$ Million) by Country, 2023 to 2033

Figure 25: North America Market Value (US$ Million) Analysis by Country, 2018 to 2033

Figure 26: North America Market Value Share (%) and BPS Analysis by Country, 2023 to 2033

Figure 27: North America Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033

Figure 28: North America Market Value (US$ Million) Analysis by Product Type, 2018 to 2033

Figure 29: North America Market Value Share (%) and BPS Analysis by Product Type, 2023 to 2033

Figure 30: North America Market Y-o-Y Growth (%) Projections by Product Type, 2023 to 2033

Figure 31: North America Market Value (US$ Million) Analysis by Indication, 2018 to 2033

Figure 32: North America Market Value Share (%) and BPS Analysis by Indication, 2023 to 2033

Figure 33: North America Market Y-o-Y Growth (%) Projections by Indication, 2023 to 2033

Figure 34: North America Market Value (US$ Million) Analysis by End User, 2018 to 2033

Figure 35: North America Market Value Share (%) and BPS Analysis by End User, 2023 to 2033

Figure 36: North America Market Y-o-Y Growth (%) Projections by End User, 2023 to 2033

Figure 37: North America Market Attractiveness by Product Type, 2023 to 2033

Figure 38: North America Market Attractiveness by Indication, 2023 to 2033

Figure 39: North America Market Attractiveness by End User, 2023 to 2033

Figure 40: North America Market Attractiveness by Country, 2023 to 2033

Figure 41: Latin America Market Value (US$ Million) by Product Type, 2023 to 2033

Figure 42: Latin America Market Value (US$ Million) by Indication, 2023 to 2033

Figure 43: Latin America Market Value (US$ Million) by End User, 2023 to 2033

Figure 44: Latin America Market Value (US$ Million) by Country, 2023 to 2033

Figure 45: Latin America Market Value (US$ Million) Analysis by Country, 2018 to 2033

Figure 46: Latin America Market Value Share (%) and BPS Analysis by Country, 2023 to 2033

Figure 47: Latin America Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033

Figure 48: Latin America Market Value (US$ Million) Analysis by Product Type, 2018 to 2033

Figure 49: Latin America Market Value Share (%) and BPS Analysis by Product Type, 2023 to 2033

Figure 50: Latin America Market Y-o-Y Growth (%) Projections by Product Type, 2023 to 2033

Figure 51: Latin America Market Value (US$ Million) Analysis by Indication, 2018 to 2033

Figure 52: Latin America Market Value Share (%) and BPS Analysis by Indication, 2023 to 2033

Figure 53: Latin America Market Y-o-Y Growth (%) Projections by Indication, 2023 to 2033

Figure 54: Latin America Market Value (US$ Million) Analysis by End User, 2018 to 2033

Figure 55: Latin America Market Value Share (%) and BPS Analysis by End User, 2023 to 2033

Figure 56: Latin America Market Y-o-Y Growth (%) Projections by End User, 2023 to 2033

Figure 57: Latin America Market Attractiveness by Product Type, 2023 to 2033

Figure 58: Latin America Market Attractiveness by Indication, 2023 to 2033

Figure 59: Latin America Market Attractiveness by End User, 2023 to 2033

Figure 60: Latin America Market Attractiveness by Country, 2023 to 2033

Figure 61: Western Europe  Market Value (US$ Million) by Product Type, 2023 to 2033

Figure 62: Western Europe  Market Value (US$ Million) by Indication, 2023 to 2033

Figure 63: Western Europe  Market Value (US$ Million) by End User, 2023 to 2033

Figure 64: Western Europe  Market Value (US$ Million) by Country, 2023 to 2033

Figure 65: Western Europe  Market Value (US$ Million) Analysis by Country, 2018 to 2033

Figure 66: Western Europe  Market Value Share (%) and BPS Analysis by Country, 2023 to 2033

Figure 67: Western Europe  Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033

Figure 68: Western Europe  Market Value (US$ Million) Analysis by Product Type, 2018 to 2033

Figure 69: Western Europe  Market Value Share (%) and BPS Analysis by Product Type, 2023 to 2033

Figure 70: Western Europe  Market Y-o-Y Growth (%) Projections by Product Type, 2023 to 2033

Figure 71: Western Europe  Market Value (US$ Million) Analysis by Indication, 2018 to 2033

Figure 72: Western Europe  Market Value Share (%) and BPS Analysis by Indication, 2023 to 2033

Figure 73: Western Europe  Market Y-o-Y Growth (%) Projections by Indication, 2023 to 2033

Figure 74: Western Europe  Market Value (US$ Million) Analysis by End User, 2018 to 2033

Figure 75: Western Europe  Market Value Share (%) and BPS Analysis by End User, 2023 to 2033

Figure 76: Western Europe  Market Y-o-Y Growth (%) Projections by End User, 2023 to 2033

Figure 77: Western Europe  Market Attractiveness by Product Type, 2023 to 2033

Figure 78: Western Europe  Market Attractiveness by Indication, 2023 to 2033

Figure 79: Western Europe  Market Attractiveness by End User, 2023 to 2033

Figure 80: Western Europe  Market Attractiveness by Country, 2023 to 2033

Figure 81: Eastern Europe  Market Value (US$ Million) by Product Type, 2023 to 2033

Figure 82: Eastern Europe  Market Value (US$ Million) by Indication, 2023 to 2033

Figure 83: Eastern Europe  Market Value (US$ Million) by End User, 2023 to 2033

Figure 84: Eastern Europe  Market Value (US$ Million) by Country, 2023 to 2033

Figure 85: Eastern Europe  Market Value (US$ Million) Analysis by Country, 2018 to 2033

Figure 86: Eastern Europe  Market Value Share (%) and BPS Analysis by Country, 2023 to 2033

Figure 87: Eastern Europe  Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033

Figure 88: Eastern Europe  Market Value (US$ Million) Analysis by Product Type, 2018 to 2033

Figure 89: Eastern Europe  Market Value Share (%) and BPS Analysis by Product Type, 2023 to 2033

Figure 90: Eastern Europe  Market Y-o-Y Growth (%) Projections by Product Type, 2023 to 2033

Figure 91: Eastern Europe  Market Value (US$ Million) Analysis by Indication, 2018 to 2033

Figure 92: Eastern Europe  Market Value Share (%) and BPS Analysis by Indication, 2023 to 2033

Figure 93: Eastern Europe  Market Y-o-Y Growth (%) Projections by Indication, 2023 to 2033

Figure 94: Eastern Europe  Market Value (US$ Million) Analysis by End User, 2018 to 2033

Figure 95: Eastern Europe  Market Value Share (%) and BPS Analysis by End User, 2023 to 2033

Figure 96: Eastern Europe  Market Y-o-Y Growth (%) Projections by End User, 2023 to 2033

Figure 97: Eastern Europe  Market Attractiveness by Product Type, 2023 to 2033

Figure 98: Eastern Europe  Market Attractiveness by Indication, 2023 to 2033

Figure 99: Eastern Europe  Market Attractiveness by End User, 2023 to 2033

Figure 100: Eastern Europe  Market Attractiveness by Country, 2023 to 2033

Figure 101: South Asia and Pacific  Market Value (US$ Million) by Product Type, 2023 to 2033

Figure 102: South Asia and Pacific  Market Value (US$ Million) by Indication, 2023 to 2033

Figure 103: South Asia and Pacific  Market Value (US$ Million) by End User, 2023 to 2033

Figure 104: South Asia and Pacific  Market Value (US$ Million) by Country, 2023 to 2033

Figure 105: South Asia and Pacific  Market Value (US$ Million) Analysis by Country, 2018 to 2033

Figure 106: South Asia and Pacific  Market Value Share (%) and BPS Analysis by Country, 2023 to 2033

Figure 107: South Asia and Pacific  Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033

Figure 108: South Asia and Pacific  Market Value (US$ Million) Analysis by Product Type, 2018 to 2033

Figure 109: South Asia and Pacific  Market Value Share (%) and BPS Analysis by Product Type, 2023 to 2033

Figure 110: South Asia and Pacific  Market Y-o-Y Growth (%) Projections by Product Type, 2023 to 2033

Figure 111: South Asia and Pacific  Market Value (US$ Million) Analysis by Indication, 2018 to 2033

Figure 112: South Asia and Pacific  Market Value Share (%) and BPS Analysis by Indication, 2023 to 2033

Figure 113: South Asia and Pacific  Market Y-o-Y Growth (%) Projections by Indication, 2023 to 2033

Figure 114: South Asia and Pacific  Market Value (US$ Million) Analysis by End User, 2018 to 2033

Figure 115: South Asia and Pacific  Market Value Share (%) and BPS Analysis by End User, 2023 to 2033

Figure 116: South Asia and Pacific  Market Y-o-Y Growth (%) Projections by End User, 2023 to 2033

Figure 117: South Asia and Pacific  Market Attractiveness by Product Type, 2023 to 2033

Figure 118: South Asia and Pacific  Market Attractiveness by Indication, 2023 to 2033

Figure 119: South Asia and Pacific  Market Attractiveness by End User, 2023 to 2033

Figure 120: South Asia and Pacific  Market Attractiveness by Country, 2023 to 2033

Figure 121: East Asia  Market Value (US$ Million) by Product Type, 2023 to 2033

Figure 122: East Asia  Market Value (US$ Million) by Indication, 2023 to 2033

Figure 123: East Asia  Market Value (US$ Million) by End User, 2023 to 2033

Figure 124: East Asia  Market Value (US$ Million) by Country, 2023 to 2033

Figure 125: East Asia  Market Value (US$ Million) Analysis by Country, 2018 to 2033

Figure 126: East Asia  Market Value Share (%) and BPS Analysis by Country, 2023 to 2033

Figure 127: East Asia  Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033

Figure 128: East Asia  Market Value (US$ Million) Analysis by Product Type, 2018 to 2033

Figure 129: East Asia  Market Value Share (%) and BPS Analysis by Product Type, 2023 to 2033

Figure 130: East Asia  Market Y-o-Y Growth (%) Projections by Product Type, 2023 to 2033

Figure 131: East Asia  Market Value (US$ Million) Analysis by Indication, 2018 to 2033

Figure 132: East Asia  Market Value Share (%) and BPS Analysis by Indication, 2023 to 2033

Figure 133: East Asia  Market Y-o-Y Growth (%) Projections by Indication, 2023 to 2033

Figure 134: East Asia  Market Value (US$ Million) Analysis by End User, 2018 to 2033

Figure 135: East Asia  Market Value Share (%) and BPS Analysis by End User, 2023 to 2033

Figure 136: East Asia  Market Y-o-Y Growth (%) Projections by End User, 2023 to 2033

Figure 137: East Asia  Market Attractiveness by Product Type, 2023 to 2033

Figure 138: East Asia  Market Attractiveness by Indication, 2023 to 2033

Figure 139: East Asia  Market Attractiveness by End User, 2023 to 2033

Figure 140: East Asia  Market Attractiveness by Country, 2023 to 2033

Figure 141: Middle East & Africa Market Value (US$ Million) by Product Type, 2023 to 2033

Figure 142: Middle East & Africa Market Value (US$ Million) by Indication, 2023 to 2033

Figure 143: Middle East & Africa Market Value (US$ Million) by End User, 2023 to 2033

Figure 144: Middle East & Africa Market Value (US$ Million) by Country, 2023 to 2033

Figure 145: Middle East & Africa Market Value (US$ Million) Analysis by Country, 2018 to 2033

Figure 146: Middle East & Africa Market Value Share (%) and BPS Analysis by Country, 2023 to 2033

Figure 147: Middle East & Africa Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033

Figure 148: Middle East & Africa Market Value (US$ Million) Analysis by Product Type, 2018 to 2033

Figure 149: Middle East & Africa Market Value Share (%) and BPS Analysis by Product Type, 2023 to 2033

Figure 150: Middle East & Africa Market Y-o-Y Growth (%) Projections by Product Type, 2023 to 2033

Figure 151: Middle East & Africa Market Value (US$ Million) Analysis by Indication, 2018 to 2033

Figure 152: Middle East & Africa Market Value Share (%) and BPS Analysis by Indication, 2023 to 2033

Figure 153: Middle East & Africa Market Y-o-Y Growth (%) Projections by Indication, 2023 to 2033

Figure 154: Middle East & Africa Market Value (US$ Million) Analysis by End User, 2018 to 2033

Figure 155: Middle East & Africa Market Value Share (%) and BPS Analysis by End User, 2023 to 2033

Figure 156: Middle East & Africa Market Y-o-Y Growth (%) Projections by End User, 2023 to 2033

Figure 157: Middle East & Africa Market Attractiveness by Product Type, 2023 to 2033

Figure 158: Middle East & Africa Market Attractiveness by Indication, 2023 to 2033

Figure 159: Middle East & Africa Market Attractiveness by End User, 2023 to 2033

Figure 160: Middle East & Africa Market Attractiveness by Country, 2023 to 2033

Recommendations

Explore Healthcare Insights

View Reports

Female Pelvic Implants Market